$Veru Inc (VERU.US)$Veru (NASDAQ:VERU) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 25 percent increase over losses of $(0.08) per share from the same period last year.
1
4
Report
Teddy123
:
Don't understand how this one doesn't garner some attention
$Veru Inc (VERU.US)$ The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial. The body composition data is particularly compelling - while placebo + s...
Major Medical Cannabis Breakthrough: Aurora Unlocks Australia-Wide Patient Access to Top-Ranked Products
Double Dose: Canopy Growth's New Cannabis Beverages Pack Root Beer and Cream Soda with Enhanced THC+CBG
taking a position here earning this morning
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...
No comment yet